Symbols / XBIO Stock $3.00 -4.15% Xenetic Biosciences, Inc.
XBIO (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
Current target
—
Low
—
High
—
Mean
—
- Xenetic Biosciences Grants Equity Award to Interim CEO - The Globe and Mail Sat, 25 Apr 2026 22
- Xenetic Biosciences (NASDAQ: XBIO) grants CEO/CFO 100,000 restricted shares - Stock Titan Fri, 24 Apr 2026 21
- Xenetic Biosciences (XBIO) interim CEO awarded 100,000-share restricted stock grant - Stock Titan hu, 23 Apr 2026 21
- Should I buy Xenetic Biosciences (XBIO) - Zacks Investment Research ue, 12 Aug 2025 07
- XBIO Shares Skyrocket: Exploring the Surge - StocksToTrade Wed, 08 Oct 2025 07
- XBIO Q2 2025 Earnings: Xenetic Biosciences Inc. beats EPS views, reports zero revenue - Crowd Trend Signals - Cổng thông tin điện tử Tỉnh Sơn La hu, 09 Apr 2026 07
- Xenetic Biosciences (XBIO) Stock Rallies on Launch (Bullish Sentiment) 2026-04-15 - Crowd Entry Points - Cổng thông tin điện tử tỉnh Lào Cai Wed, 15 Apr 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Wed, 14 Feb 2024 13
- Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges - Benzinga Fri, 10 Oct 2025 07
- Xenetic Biosciences (NASDAQ: XBIO) updates CEO pay, ownership in 10-K/A - Stock Titan Fri, 24 Apr 2026 21
- XBIO Forecast — Price Prediction for 2026. Should I Buy XBIO? - Intellectia AI Mon, 02 Jun 2025 06
- Market Movers | Winners: NCL, XBIO, NXL | Losers: CENN, ZNB, COCH - Trefis hu, 09 Oct 2025 07
- Cancer drug research from Xenetic gets June poster slot at ASCO - Stock Titan Wed, 22 Apr 2026 13
- XBIO Q4 Earnings: Beats Estimates by $0.20 - Cổng thông tin điện tử tỉnh Tây Ninh Fri, 03 Apr 2026 07
- Why Are Pharmaceutical Stocks XBIO, UPC, XTLB, & ACXP Up Today? - TipRanks Wed, 08 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2.98
+19.04%
|
2.50
-1.56%
|
2.54
+48.80%
|
1.71
|
| Operating Revenue |
|
2.98
+19.04%
|
2.50
-1.56%
|
2.54
+48.80%
|
1.71
|
| Operating Expense |
|
5.81
-13.33%
|
6.70
-4.97%
|
7.06
-16.25%
|
8.42
|
| Research And Development |
|
3.07
-6.78%
|
3.29
-5.91%
|
3.49
-26.75%
|
4.77
|
| Selling General And Administration |
|
2.75
-19.64%
|
3.42
-4.06%
|
3.56
-2.55%
|
3.65
|
| General And Administrative Expense |
|
2.75
-19.64%
|
3.42
-4.06%
|
3.56
-2.55%
|
3.65
|
| Other Gand A |
|
2.75
-19.64%
|
3.42
-4.06%
|
3.56
-2.55%
|
3.65
|
| Total Expenses |
|
5.81
-13.33%
|
6.70
-4.97%
|
7.06
-16.25%
|
8.42
|
| Operating Income |
|
-2.83
+32.58%
|
-4.20
+6.89%
|
-4.52
+32.78%
|
-6.72
|
| Total Operating Income As Reported |
|
-2.83
+32.58%
|
-4.20
+6.89%
|
-4.52
+32.78%
|
-6.72
|
| EBITDA |
|
-2.83
+32.58%
|
-4.20
+6.89%
|
-4.52
+32.51%
|
-6.69
|
| Normalized EBITDA |
|
-2.83
+32.58%
|
-4.20
+6.89%
|
-4.52
+32.51%
|
-6.69
|
| Reconciled Depreciation |
|
—
|
—
|
0.00
-100.00%
|
0.03
|
| EBIT |
|
-2.83
+32.58%
|
-4.20
+6.89%
|
-4.52
+32.78%
|
-6.72
|
| Total Unusual Items |
|
—
|
—
|
—
|
—
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
—
|
—
|
| Special Income Charges |
|
—
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
—
|
—
|
—
|
—
|
| Net Income |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Pretax Income |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Net Non Operating Interest Income Expense |
|
0.15
-40.77%
|
0.25
-29.77%
|
0.36
+112.83%
|
0.17
|
| Net Interest Income |
|
0.15
-40.77%
|
0.25
-29.77%
|
0.36
+112.83%
|
0.17
|
| Interest Income Non Operating |
|
0.15
-40.77%
|
0.25
-29.77%
|
0.36
+112.83%
|
0.17
|
| Interest Income |
|
0.15
-40.77%
|
0.25
-29.77%
|
0.36
+112.83%
|
0.17
|
| Other Income Expense |
|
0.01
+200.30%
|
-0.01
-122.49%
|
0.03
+1689.23%
|
-0.00
|
| Other Non Operating Income Expenses |
|
0.01
+200.30%
|
-0.01
-122.49%
|
0.03
+1689.23%
|
-0.00
|
| Tax Provision |
|
—
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Net Income From Continuing And Discontinued Operation |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Net Income Continuous Operations |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Normalized Income |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Net Income Common Stockholders |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Diluted EPS |
|
-1.58
+38.52%
|
-2.57
+5.17%
|
-2.71
+41.21%
|
-4.61
|
| Basic EPS |
|
-1.58
+38.52%
|
-2.57
+5.17%
|
-2.71
+41.21%
|
-4.61
|
| Basic Average Shares |
|
1.70
+10.40%
|
1.54
+0.86%
|
1.53
+7.44%
|
1.42
|
| Diluted Average Shares |
|
1.70
+10.40%
|
1.54
+0.86%
|
1.53
+7.44%
|
1.42
|
| Diluted NI Availto Com Stockholders |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
8.36
+21.19%
|
6.90
-34.92%
|
10.61
-27.96%
|
14.72
|
| Current Assets |
|
8.05
+22.20%
|
6.59
-31.29%
|
9.59
-29.78%
|
13.65
|
| Cash Cash Equivalents And Short Term Investments |
|
7.88
+27.87%
|
6.17
-31.36%
|
8.98
-31.41%
|
13.10
|
| Cash And Cash Equivalents |
|
7.88
+27.87%
|
6.17
-31.36%
|
8.98
-31.41%
|
13.10
|
| Cash Financial |
|
7.88
+27.87%
|
6.17
-31.36%
|
8.98
-31.41%
|
13.10
|
| Prepaid Assets |
|
—
|
—
|
—
|
0.56
|
| Other Current Assets |
|
0.17
-60.59%
|
0.42
-30.12%
|
0.60
+8.58%
|
0.56
|
| Total Non Current Assets |
|
0.31
+0.00%
|
0.31
-69.17%
|
1.02
-4.55%
|
1.07
|
| Net PPE |
|
—
|
—
|
—
|
—
|
| Gross PPE |
|
—
|
—
|
—
|
—
|
| Accumulated Depreciation |
|
—
|
—
|
—
|
—
|
| Machinery Furniture Equipment |
|
—
|
—
|
—
|
—
|
| Other Non Current Assets |
|
0.31
+0.00%
|
0.31
-69.17%
|
1.02
-4.55%
|
1.07
|
| Total Liabilities Net Minority Interest |
|
0.97
+8.25%
|
0.89
+10.46%
|
0.81
-24.56%
|
1.07
|
| Current Liabilities |
|
0.97
+8.25%
|
0.89
+10.46%
|
0.81
-24.56%
|
1.07
|
| Payables And Accrued Expenses |
|
0.94
+9.78%
|
0.86
+12.97%
|
0.76
-26.31%
|
1.03
|
| Payables |
|
0.26
-8.99%
|
0.28
+17.76%
|
0.24
-16.19%
|
0.29
|
| Accounts Payable |
|
0.26
-8.99%
|
0.28
+17.76%
|
0.24
-16.19%
|
0.29
|
| Current Accrued Expenses |
|
0.69
+19.01%
|
0.58
+10.75%
|
0.52
-30.21%
|
0.75
|
| Other Current Liabilities |
|
0.02
-30.20%
|
0.03
-29.12%
|
0.05
+20.79%
|
0.04
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Stockholders Equity |
|
7.40
+23.12%
|
6.01
-38.67%
|
9.80
-28.22%
|
13.65
|
| Common Stock Equity |
|
7.39
+23.13%
|
6.01
-38.68%
|
9.79
-28.22%
|
13.64
|
| Capital Stock |
|
0.00
+11.91%
|
0.00
+0.03%
|
0.00
-22.03%
|
0.00
|
| Common Stock |
|
0.00
+48.48%
|
0.00
+0.06%
|
0.00
+1.58%
|
0.00
|
| Preferred Stock |
|
0.00
-19.40%
|
0.00
+0.00%
|
0.00
-34.97%
|
0.00
|
| Share Issued |
|
2.29
+48.48%
|
1.54
+0.09%
|
1.54
+1.58%
|
1.52
|
| Ordinary Shares Number |
|
2.29
+48.56%
|
1.54
+0.09%
|
1.54
+1.58%
|
1.52
|
| Treasury Shares Number |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.07%
|
0.00
|
| Additional Paid In Capital |
|
212.29
+1.95%
|
208.23
+0.08%
|
208.05
+0.14%
|
207.77
|
| Retained Earnings |
|
-199.88
-1.36%
|
-197.19
-2.05%
|
-193.23
-2.19%
|
-189.10
|
| Gains Losses Not Affecting Retained Earnings |
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
|
| Treasury Stock |
|
5.28
+0.00%
|
5.28
+0.00%
|
5.28
+0.00%
|
5.28
|
| Other Equity Adjustments |
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
+0.00%
|
0.25
|
| Total Equity Gross Minority Interest |
|
7.40
+23.12%
|
6.01
-38.67%
|
9.80
-28.22%
|
13.65
|
| Total Capitalization |
|
7.40
+23.12%
|
6.01
-38.67%
|
9.80
-28.22%
|
13.65
|
| Working Capital |
|
7.08
+24.39%
|
5.69
-35.14%
|
8.78
-30.23%
|
12.58
|
| Invested Capital |
|
7.39
+23.13%
|
6.01
-38.68%
|
9.79
-28.22%
|
13.64
|
| Net Tangible Assets |
|
7.40
+23.12%
|
6.01
-38.67%
|
9.80
-28.22%
|
13.65
|
| Tangible Book Value |
|
7.39
+23.13%
|
6.01
-38.68%
|
9.79
-28.22%
|
13.64
|
| Preferred Stock Equity |
|
0.00
-19.40%
|
0.00
+0.00%
|
0.00
-34.97%
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.29
+18.84%
|
-2.82
+31.52%
|
-4.11
+11.46%
|
-4.65
|
| Cash Flow From Continuing Operating Activities |
|
-2.29
+18.84%
|
-2.82
+31.52%
|
-4.11
+11.46%
|
-4.65
|
| Net Income From Continuing Operations |
|
-2.68
+32.31%
|
-3.96
+4.22%
|
-4.13
+36.90%
|
-6.55
|
| Depreciation Amortization Depletion |
|
—
|
—
|
0.00
-100.00%
|
0.03
|
| Depreciation |
|
—
|
—
|
0.00
-100.00%
|
0.03
|
| Depreciation And Amortization |
|
—
|
—
|
0.00
-100.00%
|
0.03
|
| Other Non Cash Items |
|
—
|
—
|
—
|
1.79
|
| Stock Based Compensation |
|
0.06
-62.29%
|
0.17
-39.31%
|
0.28
-44.65%
|
0.51
|
| Asset Impairment Charge |
|
—
|
—
|
—
|
—
|
| Deferred Tax |
|
—
|
—
|
—
|
—
|
| Deferred Income Tax |
|
—
|
—
|
—
|
—
|
| Change In Working Capital |
|
0.33
-66.07%
|
0.97
+469.58%
|
-0.26
+38.43%
|
-0.43
|
| Change In Prepaid Assets |
|
0.26
+40.57%
|
0.18
+481.02%
|
-0.05
+53.99%
|
-0.10
|
| Change In Payables And Accrued Expense |
|
0.07
-12.89%
|
0.08
+132.13%
|
-0.26
+24.25%
|
-0.35
|
| Change In Payable |
|
0.07
-12.89%
|
0.08
+132.13%
|
-0.26
+24.25%
|
-0.35
|
| Change In Account Payable |
|
0.07
-12.89%
|
0.08
+132.13%
|
-0.26
+24.25%
|
-0.35
|
| Change In Other Current Assets |
|
0.00
-100.00%
|
0.70
+1350.07%
|
0.05
+94.32%
|
0.03
|
| Investing Cash Flow |
|
—
|
—
|
0.00
+100.00%
|
-0.50
|
| Cash Flow From Continuing Investing Activities |
|
—
|
—
|
0.00
+100.00%
|
-0.50
|
| Capital Expenditure |
|
—
|
—
|
—
|
-0.50
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
0.00
+100.00%
|
-0.50
|
| Purchase Of Intangibles |
|
—
|
—
|
0.00
+100.00%
|
-0.50
|
| Financing Cash Flow |
|
4.00
|
0.00
|
—
|
0.00
|
| Cash Flow From Continuing Financing Activities |
|
4.00
+400471400.00%
|
0.00
|
—
|
0.00
|
| Net Common Stock Issuance |
|
4.00
+400471400.00%
|
0.00
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
-0.00
|
—
|
—
|
| Changes In Cash |
|
1.72
+160.98%
|
-2.82
+31.52%
|
-4.11
+20.06%
|
-5.15
|
| Beginning Cash Position |
|
6.17
-31.36%
|
8.98
-31.41%
|
13.10
-28.21%
|
18.24
|
| End Cash Position |
|
7.88
+27.87%
|
6.17
-31.36%
|
8.98
-31.41%
|
13.10
|
| Free Cash Flow |
|
-2.29
+18.84%
|
-2.82
+31.52%
|
-4.11
+20.06%
|
-5.15
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
4.00
+400471400.00%
|
0.00
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
4.00
+400471400.00%
|
0.00
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-24 View
- 42026-04-23 View
- 8-K2026-03-13 View
- 10-K2026-03-12 View
- 8-K2026-01-09 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 8-K2025-12-11 View
- 8-K2025-11-13 View
- 10-Q2025-11-12 View
- 8-K2025-10-14 View
- 8-K2025-08-13 View
- 10-Q2025-08-12 View
- 8-K2025-05-14 View
- 10-Q2025-05-13 View
- 8-K2025-04-10 View
- 8-K2025-03-19 View
- 10-K2025-03-18 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|